US Stock MarketDetailed Quotes

ALZN Alzamend Neuro

Watchlist
  • 1.0600
  • -0.0400-3.64%
Close Mar 28 16:00 ET
7.01MMarket Cap-0.48P/E (TTM)

Alzamend Neuro Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-61.00%1.04M
-53.20%1.36M
-72.70%962.41K
-33.17%9.94M
-74.28%850.07K
-50.96%2.66M
-6.59%2.9M
16.15%3.53M
20.71%14.87M
-14.66%3.31M
Selling and administrative expenses
-21.42%590.3K
15.70%1.05M
-34.83%755.83K
-53.09%3.48M
-59.77%666.64K
-70.36%751.17K
-42.49%904.94K
-30.12%1.16M
4.30%7.42M
-25.08%1.66M
-Selling and marketing expense
----
--304K
-83.83%40K
-66.69%247.33K
--0
----
--0
41,122.33%247.33K
4,106.42%742.6K
2,255.56%247.33K
-General and administrative expense
-21.42%590.3K
-17.90%742.98K
-21.55%715.83K
-51.58%3.24M
-52.71%666.64K
-67.16%751.17K
-31.76%904.94K
-45.00%912.46K
-5.89%6.68M
-35.96%1.41M
Research and development costs
-76.58%447.11K
-84.42%311.09K
-91.27%206.57K
-13.31%6.46M
-88.87%183.43K
-33.93%1.91M
30.25%2M
71.96%2.37M
43.15%7.45M
-0.79%1.65M
Operating profit
61.00%-1.04M
53.20%-1.36M
72.70%-962.41K
33.17%-9.94M
74.28%-850.07K
50.96%-2.66M
6.59%-2.9M
-16.15%-3.53M
-20.71%-14.87M
14.66%-3.31M
Net non-operating interest income expense
18.85%-2.02K
18.93%-3.5K
-554.28%-12.01K
-31.16%-10.1K
-182.27%-1.47K
-20.66%-2.49K
-20.15%-4.31K
-19.78%-1.84K
83.45%-7.7K
13.79%-519
Non-operating interest expense
-18.85%2.02K
-18.93%3.5K
554.28%12.01K
31.16%10.1K
182.27%1.47K
20.66%2.49K
20.15%4.31K
19.78%1.84K
-83.45%7.7K
-13.79%519
Other net income (expense)
Income before tax
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
-20.35%-14.88M
14.57%-3.31M
Income tax
Net income
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
-20.35%-14.88M
14.57%-3.31M
Net income continuous Operations
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
-20.35%-14.88M
14.57%-3.31M
Minority interest income
Net income attributable to the parent company
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
-20.35%-14.88M
14.57%-3.31M
Preferred stock dividends
53.65K
Other preferred stock dividends
Net income attributable to common stockholders
60.96%-1.04M
51.30%-1.42M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
6.56%-2.91M
-16.16%-3.53M
-20.35%-14.88M
14.57%-3.31M
Basic earnings per share
94.96%-0.19
90.97%-0.4
76.77%-1.25
35.78%-147
75.80%-1.2377
54.58%-3.77
7.71%-4.43
-19.56%-5.38
-990.00%-228.9
31.80%-5.1148
Diluted earnings per share
94.96%-0.19
90.97%-0.4
76.77%-1.25
35.78%-147
75.80%-1.2377
54.58%-3.77
7.71%-4.43
-19.56%-5.38
-990.00%-228.9
31.80%-5.1148
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -61.00%1.04M-53.20%1.36M-72.70%962.41K-33.17%9.94M-74.28%850.07K-50.96%2.66M-6.59%2.9M16.15%3.53M20.71%14.87M-14.66%3.31M
Selling and administrative expenses -21.42%590.3K15.70%1.05M-34.83%755.83K-53.09%3.48M-59.77%666.64K-70.36%751.17K-42.49%904.94K-30.12%1.16M4.30%7.42M-25.08%1.66M
-Selling and marketing expense ------304K-83.83%40K-66.69%247.33K--0------041,122.33%247.33K4,106.42%742.6K2,255.56%247.33K
-General and administrative expense -21.42%590.3K-17.90%742.98K-21.55%715.83K-51.58%3.24M-52.71%666.64K-67.16%751.17K-31.76%904.94K-45.00%912.46K-5.89%6.68M-35.96%1.41M
Research and development costs -76.58%447.11K-84.42%311.09K-91.27%206.57K-13.31%6.46M-88.87%183.43K-33.93%1.91M30.25%2M71.96%2.37M43.15%7.45M-0.79%1.65M
Operating profit 61.00%-1.04M53.20%-1.36M72.70%-962.41K33.17%-9.94M74.28%-850.07K50.96%-2.66M6.59%-2.9M-16.15%-3.53M-20.71%-14.87M14.66%-3.31M
Net non-operating interest income expense 18.85%-2.02K18.93%-3.5K-554.28%-12.01K-31.16%-10.1K-182.27%-1.47K-20.66%-2.49K-20.15%-4.31K-19.78%-1.84K83.45%-7.7K13.79%-519
Non-operating interest expense -18.85%2.02K-18.93%3.5K554.28%12.01K31.16%10.1K182.27%1.47K20.66%2.49K20.15%4.31K19.78%1.84K-83.45%7.7K-13.79%519
Other net income (expense)
Income before tax 60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M6.56%-2.91M-16.16%-3.53M-20.35%-14.88M14.57%-3.31M
Income tax
Net income 60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M6.56%-2.91M-16.16%-3.53M-20.35%-14.88M14.57%-3.31M
Net income continuous Operations 60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M6.56%-2.91M-16.16%-3.53M-20.35%-14.88M14.57%-3.31M
Minority interest income
Net income attributable to the parent company 60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M6.56%-2.91M-16.16%-3.53M-20.35%-14.88M14.57%-3.31M
Preferred stock dividends 53.65K
Other preferred stock dividends
Net income attributable to common stockholders 60.96%-1.04M51.30%-1.42M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M6.56%-2.91M-16.16%-3.53M-20.35%-14.88M14.57%-3.31M
Basic earnings per share 94.96%-0.1990.97%-0.476.77%-1.2535.78%-14775.80%-1.237754.58%-3.777.71%-4.43-19.56%-5.38-990.00%-228.931.80%-5.1148
Diluted earnings per share 94.96%-0.1990.97%-0.476.77%-1.2535.78%-14775.80%-1.237754.58%-3.777.71%-4.43-19.56%-5.38-990.00%-228.931.80%-5.1148
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call